Horizon Europe: Mission Cancer Call 2026 – single stage

Résumé

This is a 2026 call under the Horizon Europe Mission "Supporting the implementation of the Cancer Mission" administered by the Austrian Research Promotion Agency (FFG). The call uses a single-stage submission procedure. No specific budget, eligibility criteria, or detailed requirements are provided in the available information.

This is a Mission Cancer call focused on oncology research and healthcare outcomes, which does not align with Acme Corporation's core domain of semiconductors and AI. While AI may have tangential applications in cancer diagnostics, the call is fundamentally a biomedical/health mission rather than a deep tech or semiconductor innovation program, and the client's semiconductor and AI expertise would not be a strategic fit.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

Die aktuelle Ausschreibung zur Mission „Supporting the implementation of the Cancer Mission“2026 beinhaltet einstufige Topics. Im gesamten Arbeitsprogramm für die Missionen (Workprogramme) sind diese …